KCNN4 and diabetic kidney disease: The results have demonstrated that pharmacological inhibition of KCa3.1 by TRAM34 restored impaired renal injury and significantly diminished inflammatory and fibrotic responses in kidneys from mice with established diabetic nephropathy.